Active substance (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Technical information
Presentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
6pNgXsePLJ4dqP6g
Listen
